<code id='A19963686A'></code><style id='A19963686A'></style>
    • <acronym id='A19963686A'></acronym>
      <center id='A19963686A'><center id='A19963686A'><tfoot id='A19963686A'></tfoot></center><abbr id='A19963686A'><dir id='A19963686A'><tfoot id='A19963686A'></tfoot><noframes id='A19963686A'>

    • <optgroup id='A19963686A'><strike id='A19963686A'><sup id='A19963686A'></sup></strike><code id='A19963686A'></code></optgroup>
        1. <b id='A19963686A'><label id='A19963686A'><select id='A19963686A'><dt id='A19963686A'><span id='A19963686A'></span></dt></select></label></b><u id='A19963686A'></u>
          <i id='A19963686A'><strike id='A19963686A'><tt id='A19963686A'><pre id='A19963686A'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:556
          Micky Tripathi Office of the National Coordinator for Health Information Technology

          Micky Tripathi is equal parts excited — and deeply concerned — about the technological change sweeping through medicine.

          As adoption of generative AI races ahead,  his job as National Coordinator for Health Information Technology under President Joe Biden is to manage this change, and keep it safe and organized. But how do you organize a pell-mell rush? How do you keep chaos safe?

          advertisement

          “It’s definitely changed my life,” Tripathi said of his official remit, which also led to his appointment as co-chair of a task force on AI within the Department of Health and Human Services.  “We believe it’s really, really important that we be out ahead of this.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc